Type 2 diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: Venlafaxine manufactured by Abidi´s Pharmaceutical Company 75 -150 milligram per day for 12 weeks. Intervention 2: Control group: Bupropione manufactured by Abidi´s
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age 18 years and over The presence of depressive symptoms in psychiatric clinical interview Confirmation of type 2 diabetes mellitus based on the diagnosis of research´s endocrinologist
Exclusion criteria
Exclusion criteria: Pregnancy and breast feeding Previous history of high mood, serious suicidal ideation and dementia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depressive symptoms. Timepoint: At baseline and at the end of the 12th week after intervention. Method of measurement: Beck Depression Inventory.;Blood glucose. Timepoint: At baseline and at the end of the 12th week after intervention. Method of measurement: Fasting blood glucose; 2 hours post-prandial blood glucose and hemoglobin A1C. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: At baseline and at the end of the 12th week after intervention. Method of measurement: Medical visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSussan Moudi, MD
Babol University of Medical Sciences
Outcome results
None listed